{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:46:56Z","timestamp":1781790416085,"version":"3.54.5"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.nano.2025.102869","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:46:04Z","timestamp":1760543164000},"page":"102869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Nanotechnology-based delivery strategies for drugs and vaccines targeting blood stage malaria: A systematic review"],"prefix":"10.1016","volume":"70","author":[{"given":"Yohana","family":"Amos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarence","family":"Rubaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elingarami","family":"Sauli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hulda","family":"Swai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneth","family":"Tumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nano.2025.102869_bb0005","first-page":"242","article-title":"Malaria endemicity in sub-Saharan Africa: past and present issues in public health","volume":"4","author":"Kolawole","year":"2023","journal-title":"Microbes Infect Dis"},{"key":"10.1016\/j.nano.2025.102869_bb0010","series-title":"World Malaria Report 2024: Addressing Inequity in the Global Malaria Response","author":"World Health Organization","year":"2024"},{"issue":"3","key":"10.1016\/j.nano.2025.102869_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(24)00016-8","article-title":"The 2023 WHO world malaria report","volume":"5","author":"Venkatesan","year":"2024","journal-title":"Lancet Microbe"},{"issue":"1","key":"10.1016\/j.nano.2025.102869_bb0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/JVBD.JVBD_45_24","article-title":"Bridging the gaps: prioritizing research strategies for enhanced malaria control and elimination","volume":"62","author":"Alghamdi","year":"2025","journal-title":"J Vector Borne Dis"},{"key":"10.1016\/j.nano.2025.102869_bb0025","series-title":"Malaria","author":"Gupta","year":"2019"},{"key":"10.1016\/j.nano.2025.102869_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2726-6","article-title":"Red blood cell tension protects against severe malaria in the Dantu blood group","author":"Kariuki","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.nano.2025.102869_bb0035","first-page":"1","article-title":"Plasmodium falciparum","volume":"35","author":"Maier","year":"2019","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.nano.2025.102869_bb0040","doi-asserted-by":"crossref","DOI":"10.15419\/ajhs.v7i2.492","article-title":"Pathophysiology of severe malaria infection","volume":"7","author":"Ohiagu","year":"2021","journal-title":"Asian J Health Sci"},{"key":"10.1016\/j.nano.2025.102869_bb0045","doi-asserted-by":"crossref","first-page":"e591","DOI":"10.1016\/S1473-3099(24)00141-5","article-title":"The emergence of artemisinin partial resistance in Africa: how do we respond?","volume":"24","author":"Rosenthal","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.nano.2025.102869_bb0050","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00109-24","article-title":"Artemisinin-resistant malaria","volume":"37","author":"White","year":"2024","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.nano.2025.102869_bb0055","first-page":"403","article-title":"Antimalarial drug toxicity: an updated brief review","volume":"54","author":"Tangpukdee","year":"2023","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"6","key":"10.1016\/j.nano.2025.102869_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/pr11061811","article-title":"Quinine: redesigned and rerouted","volume":"11","author":"Agbo","year":"2023","journal-title":"Processes"},{"key":"10.1016\/j.nano.2025.102869_bb0065","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2174\/1574886313666181109150157","article-title":"Delayed hemolytic anemia after treatment with artesunate: case report and literature review","volume":"14","author":"Salehi","year":"2019","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.nano.2025.102869_bb0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijid.2019.08.030","article-title":"Systematic review of artesunate pharmacokinetics: implication for treatment of resistant malaria","volume":"89","author":"Kouakou","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.nano.2025.102869_bb0075","series-title":"Relationship Between Anaemia, Glucose-6-phosphate Dehydrogenase Deficiency and Oxidative Stress Among Malaria Patients Visiting ESUT Teaching Hospital Enugu, Nigeria","author":"Nwabueze","year":"2018"},{"issue":"3","key":"10.1016\/j.nano.2025.102869_bb0080","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/14740338.2021.1859476","article-title":"Tafenoquine: a toxicity overview","volume":"20","author":"Chu","year":"2021","journal-title":"Expert Opin Drug Saf"},{"issue":"5","key":"10.1016\/j.nano.2025.102869_bb0085","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.4269\/ajtmh.20-1095","article-title":"Atovaquone\/proguanil resistance in an imported malaria case in Chile","volume":"104","author":"Chenet","year":"2021","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.nano.2025.102869_bb0090","first-page":"137","article-title":"Effect of food\/beverage and selected drugs on the oral absorption of Artemether-Lumefantrine tablet: an in situ and in vivo study","volume":"57","author":"Awofisayo","year":"2019","journal-title":"Bull Fac Pharm Cairo Univ"},{"key":"10.1016\/j.nano.2025.102869_bb0095","series-title":"Assessment of Long-term Health Effects of Antimalarial Drugs When Used for Prophylaxis","author":"National Academies of Sciences, Engineering, and Medicine","year":"2020"},{"issue":"5","key":"10.1016\/j.nano.2025.102869_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10050713","article-title":"Mosquirix\u2122 RTS,S\/AS01 vaccine development, immunogenicity, and efficacy","volume":"10","author":"Nadeem","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.nano.2025.102869_bb0105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","author":"RTS,S Clinical Trials Partnership","year":"2015","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.nano.2025.102869_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003377","article-title":"Estimated impact of RTS,S\/AS01 malaria vaccine allocation strategies in sub-Saharan Africa: a modelling study","volume":"17","author":"Hogan","year":"2020","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.nano.2025.102869_bb0115","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1080\/21645515.2019.1669415","article-title":"RTS, S\/AS01 vaccine (Mosquirix\u2122): an overview","volume":"16","author":"Laurens","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"10287","key":"10.1016\/j.nano.2025.102869_bb0120","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0140-6736(21)00943-0","article-title":"Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial","volume":"397","author":"Datoo","year":"2021","journal-title":"Lancet"},{"issue":"10426","key":"10.1016\/j.nano.2025.102869_bb0125","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0140-6736(23)02716-2","article-title":"R21\/Matrix-M vaccine: optimising supply, maximising impact","volume":"403","author":"Nnaji","year":"2024","journal-title":"Lancet"},{"issue":"10475","key":"10.1016\/j.nano.2025.102869_bb0130","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0140-6736(24)02777-6","article-title":"The R21\/Matrix-M malaria vaccine: questions remain","volume":"405","author":"Li","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.nano.2025.102869_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105364","article-title":"PfSPZ vaccine induces focused humoral immune response in HIV positive and negative Tanzanian adults","volume":"108","author":"Tumbo","year":"2024","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.nano.2025.102869_bb0140","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.pedhc.2024.05.010","article-title":"Examining vaccine hesitancy among Ghanaian parents for the R21\/Matrix-M malaria vaccine","volume":"38","author":"Ghazy","year":"2024","journal-title":"J Pediatr Health Care"},{"key":"10.1016\/j.nano.2025.102869_bb0145","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.3389\/fimmu.2018.02224","article-title":"Nanoparticle vaccines against infectious diseases","volume":"9","author":"Pati","year":"2018","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.nano.2025.102869_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10111946","article-title":"Nanoparticle-based delivery systems for vaccines","volume":"10","author":"Bezbaruah","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.nano.2025.102869_bb0155","article-title":"Nanomaterial-based delivery of vaccine through nasal route: opportunities, challenges, advantages, and limitations","volume":"74","author":"Kumar","year":"2022","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.nano.2025.102869_bb0160","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3390\/vaccines10040505","article-title":"Efficacy and immune response elicited by gold nanoparticle-based nanovaccines against infectious diseases","volume":"10","author":"Sengupta","year":"2022","journal-title":"Vaccines"},{"issue":"7","key":"10.1016\/j.nano.2025.102869_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/polym15071596","article-title":"Nanoparticles as drug delivery systems: a review of the implication of nanoparticles\u2019 physicochemical properties on responses in biological systems","volume":"15","author":"Yusuf","year":"2023","journal-title":"Polymers"},{"issue":"2","key":"10.1016\/j.nano.2025.102869_bb0170","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10311-018-00841-1","article-title":"Nanocarriers for drug delivery applications","volume":"17","author":"Chamundeeswari","year":"2019","journal-title":"Environ Chem Lett"},{"issue":"5","key":"10.1016\/j.nano.2025.102869_bb0175","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1021\/acs.molpharmaceut.7b01103","article-title":"Iron oxide nanoparticles-based vaccine delivery for cancer treatment","volume":"15","author":"Zhao","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2025.102869_bb0180","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/1061186X.2022.2164290","article-title":"Opportunity in nanomedicine to counter the challenges of current drug delivery approaches used for the treatment of malaria: a review","volume":"31","author":"Rajwar","year":"2023","journal-title":"J Drug Target"},{"issue":"37","key":"10.1016\/j.nano.2025.102869_bb0185","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.2174\/1381612825666191014171354","article-title":"Nanoparticle-mediated drug delivery: blood-brain barrier as the main obstacle to treating infectious diseases in CNS","volume":"25","author":"Gondim","year":"2019","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.nano.2025.102869_bb0190","author":"Amos"},{"key":"10.1016\/j.nano.2025.102869_bb0195","series-title":"AMIA Annual Symposium Proceedings. 2006","first-page":"359","article-title":"Evaluation of PICO as a knowledge representation for clinical questions","author":"Huang","year":"2006"},{"issue":"8","key":"10.1016\/j.nano.2025.102869_bb0200","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/10837450.2021.1948568","article-title":"Recent advances in targeting malaria with nanotechnology-based drug carriers","volume":"26","author":"Rashidzadeh","year":"2021","journal-title":"Pharm Dev Technol"},{"issue":"12","key":"10.1016\/j.nano.2025.102869_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13122189","article-title":"Review of the current landscape of the potential of nanotechnology for future malaria diagnosis, treatment, and vaccination strategies","volume":"13","author":"Guasch-Girbau","year":"2021","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.nano.2025.102869_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/publications10030028","article-title":"Malaria publications before and during COVID-19 pandemic: a bibliometric analysis","volume":"10","author":"Mala","year":"2022","journal-title":"Publications"},{"key":"10.1016\/j.nano.2025.102869_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202502315","article-title":"Nanoparticle therapeutics in clinical perspective: classification, marketed products, and regulatory landscape","author":"Desai","year":"2025","journal-title":"Small"},{"issue":"2","key":"10.1016\/j.nano.2025.102869_bb0220","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jconrel.2011.01.001","article-title":"A nanovector with complete discrimination for targeted delivery to Plasmodium falciparum-infected versus non-infected red blood cells in vitro","volume":"151","author":"Urb\u00e1n","year":"2011","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2025.102869_bb0225","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jconrel.2016.09.006","article-title":"Development of drug-loaded immunoliposomes for the selective targeting and elimination of rosetting Plasmodium falciparum-infected red blood cells","volume":"241","author":"Moles","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2025.102869_bb0230","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.biomaterials.2017.08.020","article-title":"ImmunoPEGliposomes for the targeted delivery of novel lipophilic drugs to red blood cells in a falciparum malaria murine model","volume":"145","author":"Moles","year":"2017","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.nano.2025.102869_bb0235","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.nano.2014.06.002","article-title":"Application of heparin as a dual agent with antimalarial and liposome targeting activities toward Plasmodium-infected red blood cells","volume":"10","author":"Marques","year":"2014","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"2","key":"10.1016\/j.nano.2025.102869_bb0240","article-title":"Heparin-coated liposomes improve antiplasmodial activity and reduce the toxicity of poupartone B","volume":"7","author":"Ledoux","year":"2020","journal-title":"Planta Med Int Open"},{"key":"10.1016\/j.nano.2025.102869_bb0245","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1248\/bpb.b15-00310","article-title":"Evaluation of phosphatidylserine-specific peptide-conjugated liposomes using a model system of malaria-infected erythrocytes","volume":"38","author":"Tagami","year":"2015","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.nano.2025.102869_bb0250","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-018-2302-9","article-title":"In vitro evaluation of chloroquine-loaded and heparin surface-functionalized solid lipid nanoparticles","volume":"17","author":"Muga","year":"2018","journal-title":"Malar J"},{"key":"10.1016\/j.nano.2025.102869_bb0255","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.colsurfa.2017.08.016","article-title":"Intravenous human serum albumin (HSA)-bound artemether nanoparticles for treatment of severe malaria","volume":"536","author":"Boateng-Marfo","year":"2018","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"issue":"3","key":"10.1016\/j.nano.2025.102869_bb0260","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1080\/03639045.2021.1892737","article-title":"Choline and PEG dually modified artemether nano delivery system targeting intra-erythrocytic Plasmodium and its pharmacodynamics in vivo","volume":"47","author":"Wang","year":"2021","journal-title":"Drug Dev Ind Pharm"},{"issue":"24","key":"10.1016\/j.nano.2025.102869_bb0265","doi-asserted-by":"crossref","first-page":"6636","DOI":"10.1016\/j.biomaterials.2014.04.058","article-title":"Parasite impairment by targeting Plasmodium-infected RBCs using glyceryl-dilaurate nanostructured lipid carriers","volume":"35","author":"Jain","year":"2014","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.nano.2025.102869_bb0270","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/1872208313666181204095314","article-title":"Development insights of surface-modified lipid nanoemulsions of dihydroartemisinin for malaria chemotherapy: characterization and in vivo antimalarial evaluation","volume":"13","author":"Umeyor","year":"2019","journal-title":"Recent Pat Biotechnol"},{"issue":"2","key":"10.1016\/j.nano.2025.102869_bb0275","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1021\/acsinfecdis.3c00564","article-title":"Enhanced antimalarial and antisequestration activity of methoxybenzenesulfonate-modified biopolymers and nanoparticles for tackling severe malaria","volume":"10","author":"Najer","year":"2024","journal-title":"ACS Infect Dis"},{"issue":"11","key":"10.1016\/j.nano.2025.102869_bb0280","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1021\/acs.molpharmaceut.4c00520","article-title":"Design and antimalarial evaluation of polydopamine-modified methyl artelinate nanoparticles","volume":"21","author":"Li","year":"2024","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2025.102869_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121665","article-title":"Design of red blood cell membrane-cloaked dihydroartemisinin nanoparticles with enhanced antimalarial efficacy","volume":"618","author":"Zuo","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2025.102869_bb0290","article-title":"Co-encapsulation of antimalarial drug and SPIO in glucose-conjugated polymeric micelles against parasite-infected erythrocytes","volume":"103","author":"Assawapanumat","year":"2025","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.nano.2025.102869_bb0295","doi-asserted-by":"crossref","first-page":"10165","DOI":"10.2147\/IJN.S227914","article-title":"Effects of surface characteristics of polymeric nanocapsules on the pharmacokinetics and efficacy of antimalarial quinine","volume":"14","author":"Michels","year":"2019","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2025.102869_bb0300","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jconrel.2013.12.032","article-title":"Use of poly(amidoamine) drug conjugates for the delivery of antimalarials to Plasmodium","volume":"177","author":"Urb\u00e1n","year":"2014","journal-title":"J Control Release"},{"issue":"4","key":"10.1016\/j.nano.2025.102869_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10040225","article-title":"Polyamidoamine nanoparticles for the oral administration of antimalarial drugs","volume":"10","author":"Mart\u00ed Coma-Cros","year":"2018","journal-title":"Pharmaceutics"},{"issue":"20","key":"10.1016\/j.nano.2025.102869_bb0310","doi-asserted-by":"crossref","first-page":"5980","DOI":"10.1039\/D2BM00879C","article-title":"Artesunate drug-loaded 2D nano-shuttle landing on RBCs infected with malaria parasites","volume":"10","author":"Kim","year":"2022","journal-title":"Biomater Sci"},{"issue":"1","key":"10.1016\/j.nano.2025.102869_bb0315","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1038\/s41598-018-21351-8","article-title":"Mesoporous silica nanocarriers encapsulated antimalarials with high therapeutic performance","volume":"8","author":"Amolegbe","year":"2018","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.nano.2025.102869_bb0320","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s13204-012-0130-8","article-title":"In vitro antiplasmodial activity of PDDS-coated metal oxide nanoparticles against Plasmodium falciparum","volume":"3","author":"Inbaneson","year":"2013","journal-title":"Appl Nanosci"},{"issue":"1","key":"10.1016\/j.nano.2025.102869_bb0325","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1021\/acsami.0c20070","article-title":"Enhanced antimalarial efficacy obtained by targeted delivery of artemisinin in heparin-coated magnetic hollow mesoporous nanoparticles","volume":"13","author":"Wang","year":"2021","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1\u20132","key":"10.1016\/j.nano.2025.102869_bb0330","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijpharm.2014.01.001","article-title":"Albumin-bound nanoparticles of practically water-insoluble antimalarial lead greatly enhance its efficacy","volume":"464","author":"Ibrahim","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2025.102869_bb0335","first-page":"2809","article-title":"Bio-inspired artemether-loaded human serum albumin nanoparticles for effective control of malaria-infected erythrocytes","volume":"11","author":"Sidhaye","year":"2016","journal-title":"Nanomedicine"},{"issue":"10","key":"10.1016\/j.nano.2025.102869_bb0340","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1021\/acs.molpharmaceut.7b00376","article-title":"Galactose-anchored gelatin nanoparticles for primaquine delivery and improved pharmacokinetics: a biodegradable and safe approach for effective antiplasmodial activity against P. falciparum 3D7 and in vivo hepatocyte targeting","volume":"14","author":"Kumar","year":"2017","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2025.102869_bb0345","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijpharm.2017.03.088","article-title":"Dehydroascorbate-derivatized chitosan particles for targeting antimalarial agents to infected erythrocytes","volume":"524","author":"Shafi","year":"2017","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"10.1016\/j.nano.2025.102869_bb0350","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijpharm.2015.02.011","article-title":"Preferential targeting of human erythrocytes infected with the malaria parasite Plasmodium falciparum via hexose transporter surface proteins","volume":"483","author":"Heikham","year":"2015","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.nano.2025.102869_bb0355","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-022-01709-x","article-title":"Erythrocyte membrane with CLIPPKF as biomimetic nanodecoy traps merozoites and attaches to infected red blood cells to prevent Plasmodium infection","volume":"21","author":"He","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2025.102869_bb0360","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1021\/acsapm.2c01553","article-title":"Heparin-coated dendronized hyperbranched polymers for antimalarial targeted delivery","volume":"5","author":"San Anselmo","year":"2022","journal-title":"ACS Appl Polym Mater"},{"issue":"sup3","key":"10.1016\/j.nano.2025.102869_bb0365","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/21691401.2018.1491481","article-title":"Carbon nanospheres conjugated bisphosphonates: synthesis, characterization and in vitro antimalarial activity","volume":"46","author":"Dlamini","year":"2018","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"10.1016\/j.nano.2025.102869_bb0370","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijpharm.2019.03.031","article-title":"Artesunate-heparin conjugate based nanocapsules with improved pharmacokinetics to combat malaria","volume":"562","author":"Ismail","year":"2019","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2025.102869_bb0375","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00331","article-title":"A synthetic nanoparticle-based vaccine approach targeting MSP4\/5 is immunogenic and induces moderate protection against murine blood-stage malaria","volume":"10","author":"Wilson","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2025.102869_bb0380","article-title":"Layer-by-layer delivery of multiple antigens using trimethyl chitosan nanoparticles as a malaria vaccine candidate","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2025.102869_bb0385","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1016\/j.vaccine.2011.02.033","article-title":"Effect of nanoparticle coating on the immunogenicity of plasmid DNA vaccine encoding P. yoelii MSP-1 C-terminal","volume":"29","author":"Shuaibu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2025.102869_bb0390","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3390\/vaccines8040651","article-title":"Pullulan-coated iron oxide nanoparticles for blood-stage malaria vaccine delivery","volume":"8","author":"Powles","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.nano.2025.102869_bb0395","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1096\/fj.12-218362","article-title":"Iron oxide nanoparticles as a clinically acceptable delivery platform for a recombinant blood-stage human malaria vaccine","volume":"27","author":"Pusic","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/j.nano.2025.102869_bb0400","doi-asserted-by":"crossref","first-page":"8898","DOI":"10.1016\/j.vaccine.2011.09.070","article-title":"Blood stage merozoite surface protein conjugated to nanoparticles induce potent parasite inhibitory antibodies","volume":"29","author":"Pusic","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.nano.2025.102869_bb0405","doi-asserted-by":"crossref","DOI":"10.3390\/nano7020030","article-title":"Magnetic nanovectors for the development of DNA blood-stage malaria vaccines","volume":"7","author":"Al-Deen","year":"2017","journal-title":"Nanomaterials"},{"issue":"1","key":"10.1016\/j.nano.2025.102869_bb0410","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12951-017-0295-0","article-title":"The use of a P. falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malaria","volume":"15","author":"Karch","year":"2017","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"10.1016\/j.nano.2025.102869_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/nano11020406","article-title":"Transdermal immunization of elastic liposome-laden recombinant chimeric fusion protein of P. falciparum (Pf MSP-Fu24) mounts protective immune response","volume":"11","author":"Chaudhari","year":"2021","journal-title":"Nanomaterials"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154996342500070X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154996342500070X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T03:10:15Z","timestamp":1763521815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154996342500070X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":83,"alternative-id":["S154996342500070X"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2025.102869","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanotechnology-based delivery strategies for drugs and vaccines targeting blood stage malaria: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2025.102869","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102869"}}